Carvedilol Suppresses Apoptosis and Ion Channel Remodelling of HL-1 Cardiac Myocytes Expressing E334K cMyBPC

Abstract

Background: Besides its antiarrhythmic action, carvedilol has an activity to suppress cardiac tissue damage. However, it is unknown whether it has any effect on cellular apoptosis and ion channel remodelling.

Purpose: To know whether carvedilol has any effect on apoptosis and ion channel remodeling of HL-1 cells expressing E334K MyBPC, and comparing it with bisoprolol.

Method: We examined effects of carvedilol and bisoprolol on the levels of pro- and anti-apoptotic proteins and ion channels as well as apoptosis of HL-1 cells transfected with E334K MyBPC using Western blot and flow cytometry.

Results: Carvedilol decreased the protein levels of p53, Bax and cytochrome c and increased that of Bcl-2 in HL-1 cells expressing E334K MyBPC. Bisoprolol failed to affect the protein levels. Both carvedilol and bisoprolol increased the protein levels of Cav1.2 but not that of Nav1.5. Carvedilol was stronger than bisoprolol at decreasing the number of annexin-V positive cells in HL-1 cells expressing E334K MyBPC.

Conclusion: Carvedilol suppressed apoptosis of HL-1 cells expressing E334K MyBPC through modification of pro- and anti-apoptotic proteins, whose was associated with an increase of Cav 1.2 protein expression.

Keywords

carvedilol - bisoprolol - apoptosis - Cav 1.2 - E334K MyBPC

• References

• 1 Iwai-Kanai E, Hasegawa K, Araki M et al. Alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation 1999; 100: 305-311
• 2 McGory ML, Maggard MA, Ko CY. A meta-analysis of perioperative beta blockade: what is the actual risk reduction?. Surgery 2005; 138: 171-179
• 3 Frishman WH. Carvedilol. N Engl J Med 1998; 339: 1759-1765
• 4 Yue TL, Cheng HY, Lysko PG et al. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 1992; 263: 92-98
• 5 Yue TL, Mckenna PJ, Lysko PG et al. SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant. Eur J Pharmacol 1994; 251: 237-243
• 6 Brehm BR, Wolf SC, Bertsch D et al. Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells. Cardiovasc Res 2001; 49: 430-439
• 7 McMurray J, Køber L, Robertson M et al. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol 2005; 45: 525-530
• 8 Bahrudin U, Morisaki H, Morisaki T et al. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy. J Mol Biol 2008; 384: 896-907
• 9 Bahrudin U, Morikawa K, Takeuchi A et al. Impairment of ubiquitin-proteasome system by E334K cMyBPC modifies channel proteins, leading to electrophysiological dysfunction. J Mol Biol 2011; 413: 857-878
• 10 Bahrudin U, Ikeda N, Utami SB et al. Simultaneous treatment with azelnidipine and olmesartan inhibits apoptosis of HL-1 cardiac myocytes expressing E334K cMyBPC. Drug Res 2013; 63: 515-520
• 11 White SM, Constantin PE, Claycomb WC. Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol 2004; 286: H823-H829
• 12 Yeh CH, Chen TP, Wang YC et al. Carvedilol treatment after myocardial infarct decreases cardiomyocytic apoptosis in the peri-infarct zone during cardioplegia-induced cardiac arrest. Shock 2013; 39: 343-352
• 13 Rössig L, Haendeler J, Mallat Z et al. Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. J Am Coll Cardiol 2000; 36: 2081-2089
• 14 Hesong Z, Xiaochun L, Huayue Z. Effects of carvedilol on cardiomyocyte apoptosis and gene expressionin vivo after ischemia-reperfusion in rats. J Huazhong Univ Sci Technolog Med Sci 2003; 23: 127-130
• 15 Yang YJ, Chen YF, Ruan YM et al. Beneficial effects of carvedilol on cardiomyocyte apoptosis and bcl-2/bax expression after acute myocardial infarction an experiment with rats. Nat Med J China 2006; 86: 919-922
• 16 Rehsia NS, Dhalla NS. Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure. Exp Clin Cardiol 2010; 15: e86-e95
• 17 Kishihara J, Niwano S, Niwano H et al. Effect of carvedilol on atrial remodeling in canine model of atrial fibrillation. Cardiovasc Diagn Ther 2014; 4: 28-35
• 18 Li X, Huang CX, Jiang H et al. The beta-adrenergic blocker carvedilol restores L-type calcium current in a myocardial infarction model of rabbit. Chin Med J (Engl) 2005; 118: 377-382